Best Brain Cancer doctors in Turkey: TOP 47 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by

Fahad Mawlood

Bülent Karagöz

  • 4.6 Excellent 493 reviews
  • 32 years of experience
  • Turkey, Istanbul, Anadolu Medical Center
    • Expert in brain cancer treatment, Dr. Bülent Karagöz utilizes advanced therapies.
    • Performs surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
    • International practice in countries such as Turkey, NATO KFOR regions, and Turkish Cyprus.
    • Over 20 years of oncology experience, specializing in tumor biology and immunology.
    • Accredited medical oncologist with a focus on innovative cancer treatment methods.
    • Member of the Turkish Medical Oncology Association, contributing to cancer research.
    • Consults patients online, widening access to his brain cancer expertise.
    • Speaks multiple languages, offering care to a diverse patient population.
  • Read more
Stereotaxic radiosurgery
$600 - $850
CyberKnife
$8,000 - $12,000
Info

Serkan Keskin

  • 4.6 Excellent 319 reviews
  • 24 years of experience
  • Turkey, Istanbul, Memorial Şişli Hospital
  • Dr. Serkan Keskin is a highly experienced oncologist specializing in chemotherapy. He has numerous achievements in his field, including being ranked first in the Medical Oncology Proficiency Exam in Turkey in 2012. He is an active member of various prestigious oncology societies, and has a strong academic profile with 42 articles published in international journals.
  • Read more
Craniotomy
$13,000 - $17,000
CyberKnife
$4,750 - $6,450
Info

Mustafa Solak

  • 4.5 Good 162 reviews
  • 19 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
    • Dr. Mustafa Solak specializes in cutting-edge Brain Cancer treatment.
    • Expert in surgical removal, radiation therapy, and chemotherapy for Brain Cancer.
    • International practice includes the USA at MD Anderson Cancer Center.
    • Holds a medical degree from Hacettepe University, specialized in cancer treatment.
    • Member of esteemed medical institutions for ongoing professional development.
    • Offers remote consultations for patients with Brain Cancer.
    • Fluent in English, providing care to a diverse patient base.
  • Read more
Proton-beam therapy
$800 - $1,000
Craniotomy
$6,500 - $9,000
Info

Gorkem Turkkan

  • 4.5 Good 162 reviews
  • 16 years of experience
  • Turkey, Istanbul, Hisar Hospital Intercontinental
  • Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

    After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

    He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

    He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

    MEDICAL INTERESTS

    MR-Linac

    Linac

    Stereotactic (Pinpoint) Radiotherapy

    Prostate Cancers

    Breast Cancers

    Lung Cancers

    Rectum Cancers

    Brain and Spinal Cord Cancers

    Head and Neck Cancers

    Volumetric Arc Therapy (VMAT)

    Intensity Modulated Radiotherapy (IMRT)

  • Read more
Proton-beam therapy
$800 - $1,000
Craniotomy
$6,500 - $9,000
Info

Mustafa Özdoğan

  • 4.5 Good 111 reviews
  • 25 years of experience
  • Turkey, Antalya , Memorial Antalya Hospital
  • Prof. Mustafa Özdoğan is an experienced cancer specialist with over 20 years of experience and has written over 40 articles on the topic. He is currently the Head of the Medical Oncology Department at Memorial Antalya Hospital in Turkey and holds qualifications in general medicine, internal medicine, and medical oncology. He is a member of the European Medical Oncology Association, the Turkish Medical Oncology Association, the Antalya Breast Cancer Association, and the American Clinical Oncology Association.

  • Read more
Resection of glioma
$12,600 - $12,600
Info

Nejat Akalan

  • 4.5 Good 467 reviews
  • 37 years of experience
  • Turkey, Istanbul, Medipol Mega University Hospital
  • Dr. Nejat Akalan is a leading neurosurgeon specializing in brain and nerve surgeries, with over 35 years of experience. His areas of expertise include epilepsy, glioma, skull injuries, movement disorders, spine tumors, herniations, and other nervous disorders. He uses advanced techniques in his surgeries and has published 117 scientific papers and a book.

  • Read more
Info

Find out about the best doctors here

20 top ranked Brain Cancer doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Brain Cancer doctors on Bookimed.com:

How to choose the best Brain Cancer doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Brain Cancer doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Brain Cancer varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Brain Cancer if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Sezer Saglam

  • New
  • 26 years of experience
  • Turkey, Istanbul, Gayrettepe Florence Nightingale Hospital
  • Personal Information 

    Sex:  Male

    Born : 1968 

     

    Professional Experience

    Gayrettepe Florence Nigthingale Hospital

    Medical Oncology Department

    Besiktas/Istanbul/Turkey (ongoing)

     

    Education:

    He became Professor (22/April /2016)

    Medical Oncology

     

    Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

    Istanbul University Oncology Institue,

    Department of Medical Oncology

     

    Medical Oncology Fellowship (December 2001-December2004)

    Istanbul University, Istanbul Medical Faculty

     

    Hemodialysis Traning (May1996-January1997)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Internal Medicine Residency (November 1991-November 1996)

    Istanbul University ,bCerrahpasa Medical Faculty

     

    Ege University Medical Faculty (1985-1991)

     

    Professional Experience

    February 1999-November 2001

    Metropolitan Florence Nigthingale Hospital

    American Cancer Center, Gayrettepe/İstanbul

     

    April1997- October 1998

    Bayraktar Dialysis Center

    Güngören/ Istanbul

     

    Membership

    Turkish Medical Oncology Association

    ENET(European Neuroendocrine Tumour Society)

    ESMO

    ASCO

  • Read more
Doctor's visit
Price on request
Info

Murat Sari

  • 5 Excellent 3 reviews
  • 9 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education and Career


    2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

    Medicine Department of Internal Medicine

    2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

    2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

    2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

    2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

    Memberships in Scientific Organizations

    ASCO

    ESMO

    TTOD 

    AVOD 

    Publications

    In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

    Awards Received

    EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

    "The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

    Speeches Delivered at National Congresses, Conferences, and Symposia:

     

    Courses, Meetings, and Certificates

    ESMO certified Medical Oncologist since 2019

  • Read more
Doctor's visit
Price on request
Info

Abdullah Sakin

  • 5 Excellent 2 reviews
  • 18 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  •  

    Experience

    2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

     

    2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

     

    2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

     

    2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

     

    2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

     

    2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

     

    2008 - 2012 Haseki Training and Research Hospital

     

    2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

     

     

    Education

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2007

    Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

     

  • Read more
Resection of glioma
$12,000 - $18,000
Craniotomy
$10,000 - $15,000
Resection of glioblastoma
$12,000 - $18,000
Info

Evrim Metcalfe

  • 5 Excellent 2 reviews
  • 27 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2021 year - 2022 year

    Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

    2021 year - 2022 year

    Department of Radiation Oncology, Biruni University Faculty of Medicine

    2020 year - 2021 year

    Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

    2017 year - 2020 year

    Clinical Manager of Radiation Oncology, Neolife Medical Center

    2016 year - 2017 year

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2011 year - 2016 year

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2010 year - 2011 year

    Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

    2008 year - 2010 year

    Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

    2006 year

    Medical Faculty, Dokuz Eylül University

    2006 year - 2008 year

    Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

    2000 year - 2006 year

    Medical Faculty, Dokuz Eylül University

     

    Education

    2022 year

    Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

    2022 year

    Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

    2021 year

    Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

    2017 year

    Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

    2017 year

    Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

    2006 year

    Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

    2006 year

    Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

    1998 year

    Ege University, Faculty of Medicine

     

     

  • Read more
Resection of glioma
$12,000 - $18,000
Craniotomy
$10,000 - $15,000
Resection of glioblastoma
$12,000 - $18,000
Info

Sefik Igdem

  • New
  • 29 years of experience
  • Turkey, Istanbul, Gayrettepe Florence Nightingale Hospital
  • Personal information

    Title: Professor Doctor

    Branch: Radiation Oncology

    Work History:

    1 GATA Military Medical Faculty

    2 Gayrettepe Florence Nightingale Hospital

    3 T.R. Demiroğlu Bilim University \ Associate Professor

    4 T.R Demiroğlu Bilim University \ Professor

    Medical Specialties and Subspecialties:

    1 Head and Neck Cancers

    2 Radiation Oncology

    Priority treatments:

    1 Prostate cancer

    2 Conformal treatments

    Special advanced health technologies:

    1 Truebeam Stx Technology

    2 Halcyons

    Education

    1991 - Istanbul University Istanbul Faculty of Medicine

    1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

    Oncology Specialization Training

     

  • Read more
Doctor's visit
Price on request
Info

Tahsin Ozadli

  • 4.7 Excellent 47 reviews
  • 22 years of experience
  • Turkey, Istanbul, Valued Med Hub Hospitals
  • Education and Expertise

    Selcuk University Meram Faculty of Medicine - Medical Education

    Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

     

    Experience

    Malatya State Hospital Internal Diseases Clinic

    Ankara Oncology Hospital Medical Oncology Clinic

    Erzurum Regional Training and Research Hospital Medical Oncology Clinic


    AREAS OF INTEREST

    Lung cancer

    esophageal cancer

    Gastric cancer

    breast cancer

    Gastrointestinal surgery

    https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

  • Read more
Gamma Knife
$8,500 - $8,500
Info

Sezer Saglam

  • 5 Excellent 34 reviews
  • 28 years of experience
  • accreditations:
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
  • Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

    Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

  • Read more
Doctor's visit
Price on request
Info

Turkan Ozturk Topcu

  • New
  • 15 years of experience
  • Turkey, Istanbul, Biruni University Hospital
  • Education

    Cumhuriyet University Faculty of Medicine, 2004
    Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
    Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

    Experience

    MD Andeson Cancer Center, USA, 2008
    Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
    Moffit Cancer Center , USA 2022
    Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
    İdil State Hospital Internal Medicine Clinic, 2011
    Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
    Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
    Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
    Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

     

    Scientific Membership

    Turkish Medical Association (TTB)
    Turkish Society of Medical Oncology (TTOD)
    European Society for Medical Oncology (ESMO)
    American Society of Medical Oncology (ASCO)

     

    Medical Intrests

    • Breast Cancer
    • Lung Cancer
    • Colon Cancer
    • Stomach Cancer
    • Rectal Cancer
    • Ovarian Cancer
    • Liver Cancer
    • Oesophageal Cancer - Oesophageal Cancer
    • Kidney Cancer
    • Larynx Cancer - Cancer of the Larynx
    • Thyroid Cancer
    • Head and Neck Cancers
    • Gynaecological Cancers
    • Pancreatic Cancer
    • Oesophageal Cancer - Oesophageal Cancer
    • Uterine Cancer
    • Brain Cancers - Brain Tumours
    • Soft Tissue Cancer - Sarcomas
    • Prostate Cancer
    • Bladder Cancer
    • Bile Tract Cancer
    • Testicular Cancer
    • Cervical Cancer
    • Mouth, Tongue, Lip Cancers
    • Gastrointestinal System Cancers
    • Bone Tumours
    • Trachea and Bronchial Cancers
    • Skin Cancers - Skin Cancers
    • Skeletal System Tumours
    • Gallbladder Cancer
    • Mesothelioma
  • Read more
Doctor's visit
Price on request
Info

Nail Paksoy

  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Resection of glioma
$12,000 - $18,000
Craniotomy
$10,000 - $15,000
Resection of glioblastoma
$12,000 - $18,000
Info

Tahsin Ozatli

  • 4.3 Good 16 reviews
  • 2015 years of experience
  • Turkey, Istanbul, Istinye University Liv Hospital Bahcesehir
  • Oncologist
Doctor's visit
Price on request
Info

Yusuf Acikgoz

  • 4.5 Good 3 reviews
  • 9 years of experience
  • Turkey, Ankara, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Read more
Doctor's visit
Price on request
Info

Osman Kostek

  • 5 Excellent 3 reviews
  • 21 years of experience
  • Turkey, Istanbul, Medipol Acibadem District Hospital
  • Education

    • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
    • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

    Career

    • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
    • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
    • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
  • Read more
Doctor's visit
Price on request
Info

Seyda Gunduz

  • 4.3 Good 16 reviews
  • 15 years of experience
  • Turkey, Istanbul, Istinye University Liv Hospital Bahcesehir
Doctor's visit
Price on request
Info

Tarik Salman

  • New
  • 31 years of experience
  • Turkey, İzmir, Medicalpoint International Hospital
  • Diseases

    • Lung Cancer
    • Skin Cancers
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecological Cancers
    • Colon Cancer
    • Breast Cancer
    • Rare Cancers

    Treatment Methods

    • Individual Treatments (Comprehensive Genomic Profiling)
    • Targeted Therapies
    • Immunotherapy
    • Cancer Vaccines
    • Chemotherapy
    • Clinical Research/Experimental Medical Research

    Experience

    • 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
    • 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
    • 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
    • 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
    • 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
    • 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
    • June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
    • 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
    • 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
    • 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
    • 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
    • 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
    • 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
    • 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
    • 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
    • 1995-1997: Şırnak Cizre Central Health Center
    • 1994-1995: Şırnak İdil Oyalı Village Health Center

    Professional Memberships

    • Turkish Society of Medical Oncology 2008 
    • (2018-2021 Term Board Member)
    • Izmir Oncology Group, Board Member (2014 -…)
    • Geriatric Oncology Association, Board Member (2015-…)
    • Mediterranean Oncology Association Board Member (2020 -…)
    • Turkish Biochemistry Association, Member, 2016
    • European Society of Medical Oncology, Member, 2012
    • American Society of Clinical Oncology, Member, 2008
  • Read more
Doctor's visit
Price on request
Info

Choosing Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team